+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Cancer Registry Software Market, by Type, by Deployment Type, by Component, by End User, by Region, Industry Analysis and Forecast, 2019 - 2025

  • ID: 5006150
  • Report
  • February 2020
  • Region: Global
  • 236 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • C/Net Solutions
  • Conduent, Incorporated
  • Elekta AB
  • Himagine Solutions, Inc.
  • IBM Corporation
  • McKesson Corporation
  • MORE
The Global Cancer Registry Software Market size is expected to reach $90.8 Million by 2025, rising at a market growth of 10.33% CAGR during the forecast period. A cancer registry is an information system designed to collect, manage and analyze data on individuals diagnosed with the malignant or neoplastic disease (cancer). Free software applications are publicly available for collecting and analyzing cancer patients' related data. Cancer registry software offers in-depth information on state and global cancer statistics. To maintain records providing high-quality data, the National Program of Cancer Registries (NPCR) of the Centers for Disease Control and Prevention (CDC) offers support to nations and states. There are appointed registrars who need to manage and keep the registry updated.

Most of these cancer registrars are employed in hospitals. Other work settings and centers for registrars usually involve standard-setting organizations, government agencies, central or state cancer registries, pharmaceutical companies, staffing firms, software vendors, and insurance agencies. Moreover, various self-employed cancer registrars also exist in the industry. The National Cancer Registrars Association (NCRA), a non-profit association, includes registry professionals and Certified Tumor Registrars (CTR).

The cancer registry program helps to simplify data collection for national and state registries, further helping to monitor the effectiveness of different treatment strategies. In addition, the data collected by the state registries help to better identify and treat the disease. The data collected are important to attack risk factors, like sun exposure, tobacco use, or certain environmental factors, including chemical and radiation exposure. Such information is also needed for places to be identified where screening and treatment services should be tracked and enhanced. In addition, registry data are useful for research institutes to estimate the efficacy of the cancer control, treatment, and prevention program.

Based on Type, the market is segmented into Integrated and Standalone. Based on Deployment Type, the market is segmented into On-premise and Cloud-based. Based on Component, the market is segmented into Commercial and Public. Based on End User, the market is segmented into Government & Third party, Research Centers, Hospital & Medical Centers, Private Payers and Pharma Biotech & Medical Device Suppliers. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include IBM Corporation, McKesson Corporation, Conduent, Incorporated, Elekta AB, Ordinal Data, Inc., Onco, Inc., C/Net Solutions, Rocky Mountain Cancer Data System, Electronic Registry System, Inc., and Himagine Solutions, Inc.

Scope of the Study

Market Segmentation:

By Type
  • Integrated
  • Standalone
By Deployment Type
  • On-premise
  • Cloud-based
By Component
  • Commercial
  • Public
By End User
  • Government & Third party
  • Research Centers
  • Hospital & Medical Centers
  • Private Payers
  • Pharma Biotech & Medical Device Suppliers
By Geography

North America
  • US
  • Canada
  • Mexico
  • Rest of North America
Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA
Companies Profiled
  • IBM Corporation
  • McKesson Corporation
  • Conduent, Incorporated
  • Elekta AB
  • Ordinal Data, Inc.
  • Onco, Inc.
  • C/Net Solutions
  • Rocky Mountain Cancer Data System
  • Electronic Registry System, Inc.
  • Himagine Solutions, Inc.
Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • C/Net Solutions
  • Conduent, Incorporated
  • Elekta AB
  • Himagine Solutions, Inc.
  • IBM Corporation
  • McKesson Corporation
  • MORE
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Cancer Registry Software Market, by Type
1.4.2 Global Cancer Registry Software Market, by Deployment Type
1.4.3 Global Cancer Registry Software Market, by Component
1.4.4 Global Cancer Registry Software Market, by End User
1.4.5 Global Cancer Registry Software Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Global Cancer Registry Software Market by Type
3.1 Global Integrated Cancer Registry Software Market by Region
3.2 Global Standalone Cancer Registry Software Market by Region

Chapter 4. Global Cancer Registry Software Market by Deployment Model
4.1 Global On-premise Cancer Registry Software Market by Region
4.1.1 Global Cloud-based Cancer Registry Software Market by Region

Chapter 5. Global Cancer Registry Software Market by Component
5.1 Global Commercial Cancer Registry Software Market by Region
5.2 Global Public Cancer Registry Software Market by Region

Chapter 6. Global Cancer Registry Software Market by End User
6.1 Global Government & Third party Market by Region
6.2 Global Research Centers Market by Region
6.3 Global Hospital & Medical Centers Market by Region
6.4 Global Private Payers Market by Region
6.5 Global Pharma biotech & medical device suppliers Market by Region

Chapter 7. Global Cancer Registry Software Market by Region
7.1 North America Cancer Registry Software Market
7.1.1 North America Cancer Registry Software Market by Type
7.1.1.1 North America Integrated Cancer Registry Software Market by Country
7.1.1.2 North America Standalone Cancer Registry Software Market by Country
7.1.2 North America Cancer Registry Software Market by Deployment Model
7.1.2.1 North America On-premise Cancer Registry Software Market by Country
7.1.2.2 North America Cloud-based Cancer Registry Software Market by Country
7.1.3 North America Cancer Registry Software Market by Component
7.1.3.1 North America Commercial Cancer Registry Software Market by Country
7.1.3.2 North America Public Cancer Registry Software Market by Country
7.1.4 North America Cancer Registry Software Market by End User
7.1.4.1 North America Government & Third party Market by Country
7.1.4.2 North America Research Centers Market by Country
7.1.4.3 North America Hospital & Medical Centers Market by Country
7.1.4.4 North America Private Payers Market by Country
7.1.4.5 North America Pharma biotech & medical device suppliers Market by Country
7.1.5 North America Cancer Registry Software Market by Country
7.1.5.1 USA Cancer Registry Software Market
7.1.5.1.1 USA Cancer Registry Software Market by Type
7.1.5.1.2 USA Cancer Registry Software Market by Deployment Model
7.1.5.1.3 USA Cancer Registry Software Market by Component
7.1.5.1.4 USA Cancer Registry Software Market by End User
7.1.5.2 Canada Cancer Registry Software Market
7.1.5.2.1 Canada Cancer Registry Software Market by Type
7.1.5.2.2 Canada Cancer Registry Software Market by Deployment Model
7.1.5.2.3 Canada Cancer Registry Software Market by Component
7.1.5.2.4 Canada Cancer Registry Software Market by End User
7.1.5.3 Mexico Cancer Registry Software Market
7.1.5.3.1 Mexico Cancer Registry Software Market by Type
7.1.5.3.2 Mexico Cancer Registry Software Market by Deployment Model
7.1.5.3.3 Mexico Cancer Registry Software Market by Component
7.1.5.3.4 Mexico Cancer Registry Software Market by End User
7.1.5.4 Rest of North America Cancer Registry Software Market
7.1.5.4.1 Rest of North America Cancer Registry Software Market by Type
7.1.5.4.2 Rest of North America Cancer Registry Software Market by Deployment Model
7.1.5.4.3 Rest of North America Cancer Registry Software Market by Component
7.1.5.4.4 Rest of North America Cancer Registry Software Market by End User
7.2 Europe Cancer Registry Software Market
7.2.1 Europe Cancer Registry Software Market by Type
7.2.1.1 Europe Integrated Cancer Registry Software Market by Country
7.2.1.2 Europe Standalone Cancer Registry Software Market by Country
7.2.2 Europe Cancer Registry Software Market by Deployment Model
7.2.2.1 Europe On-premise Cancer Registry Software Market by Country
7.2.2.2 Europe Cloud-based Cancer Registry Software Market by Country
7.2.3 Europe Cancer Registry Software Market by Component
7.2.3.1 Europe Commercial Cancer Registry Software Market by Country
7.2.3.2 Europe Public Cancer Registry Software Market by Country
7.2.4 Europe Cancer Registry Software Market by End User
7.2.4.1 Europe Government & Third party Market by Country
7.2.4.2 Europe Research Centers Market by Country
7.2.4.3 Europe Hospital & Medical Centers Market by Country
7.2.4.4 Europe Private Payers Market by Country
7.2.4.5 Europe Pharma biotech & medical device suppliers Market by Country
7.2.5 Europe Cancer Registry Software Market by Country
7.2.5.1 Germany Cancer Registry Software Market
7.2.5.1.1 Germany Cancer Registry Software Market by Type
7.2.5.1.2 Germany Cancer Registry Software Market by Deployment Model
7.2.5.1.3 Germany Cancer Registry Software Market by Component
7.2.5.1.4 Germany Cancer Registry Software Market by End User
7.2.5.2 UK Cancer Registry Software Market
7.2.5.2.1 UK Cancer Registry Software Market by Type
7.2.5.2.2 UK Cancer Registry Software Market by Deployment Model
7.2.5.2.3 UK Cancer Registry Software Market by Component
7.2.5.2.4 UK Cancer Registry Software Market by End User
7.2.5.3 France Cancer Registry Software Market
7.2.5.3.1 France Cancer Registry Software Market by Type
7.2.5.3.2 France Cancer Registry Software Market by Deployment Model
7.2.5.3.3 France Cancer Registry Software Market by Component
7.2.5.3.4 France Cancer Registry Software Market by End User
7.2.5.4 Russia Cancer Registry Software Market
7.2.5.4.1 Russia Cancer Registry Software Market by Type
7.2.5.4.2 Russia Cancer Registry Software Market by Deployment Model
7.2.5.4.3 Russia Cancer Registry Software Market by Component
7.2.5.4.4 Russia Cancer Registry Software Market by End User
7.2.5.5 Spain Cancer Registry Software Market
7.2.5.5.1 Spain Cancer Registry Software Market by Type
7.2.5.5.2 Spain Cancer Registry Software Market by Deployment Model
7.2.5.5.3 Spain Cancer Registry Software Market by Component
7.2.5.5.4 Spain Cancer Registry Software Market by End User
7.2.5.6 Italy Cancer Registry Software Market
7.2.5.6.1 Italy Cancer Registry Software Market by Type
7.2.5.6.2 Italy Cancer Registry Software Market by Deployment Model
7.2.5.6.3 Italy Cancer Registry Software Market by Component
7.2.5.6.4 Italy Cancer Registry Software Market by End User
7.2.5.7 Rest of Europe Cancer Registry Software Market
7.2.5.7.1 Rest of Europe Cancer Registry Software Market by Type
7.2.5.7.2 Rest of Europe Cancer Registry Software Market by Deployment Model
7.2.5.7.3 Rest of Europe Cancer Registry Software Market by Component
7.2.5.7.4 Rest of Europe Cancer Registry Software Market by End User
7.3 Asia Pacific Cancer Registry Software Market
7.3.1 Asia Pacific Cancer Registry Software Market by Type
7.3.1.1 Asia Pacific Integrated Cancer Registry Software Market by Country
7.3.1.2 Asia Pacific Standalone Cancer Registry Software Market by Country
7.3.2 Asia Pacific Cancer Registry Software Market by Deployment Model
7.3.2.1 Asia Pacific On-premise Cancer Registry Software Market by Country
7.3.2.2 Asia Pacific Cloud-based Cancer Registry Software Market by Country
7.3.3 Asia Pacific Cancer Registry Software Market by Component
7.3.3.1 Asia Pacific Commercial Cancer Registry Software Market by Country
7.3.3.2 Asia Pacific Public Cancer Registry Software Market by Country
7.3.4 Asia Pacific Cancer Registry Software Market by End User
7.3.4.1 Asia Pacific Government & Third party Market by Country
7.3.4.2 Asia Pacific Research Centers Market by Country
7.3.4.3 Asia Pacific Hospital & Medical Centers Market by Country
7.3.4.4 Asia Pacific Private Payers Market by Country
7.3.4.5 Asia Pacific Pharma biotech & medical device suppliers Market by Country
7.3.5 Asia Pacific Cancer Registry Software Market by Country
7.3.5.1 China Cancer Registry Software Market
7.3.5.1.1 China Cancer Registry Software Market by Type
7.3.5.1.2 China Cancer Registry Software Market by Deployment Model
7.3.5.1.3 China Cancer Registry Software Market by Component
7.3.5.1.4 China Cancer Registry Software Market by End User
7.3.5.2 Japan Cancer Registry Software Market
7.3.5.2.1 Japan Cancer Registry Software Market by Type
7.3.5.2.2 Japan Cancer Registry Software Market by Deployment Model
7.3.5.2.3 Japan Cancer Registry Software Market by Component
7.3.5.2.4 Japan Cancer Registry Software Market by End User
7.3.5.3 India Cancer Registry Software Market
7.3.5.3.1 India Cancer Registry Software Market by Type
7.3.5.3.2 India Cancer Registry Software Market by Deployment Model
7.3.5.3.3 India Cancer Registry Software Market by Component
7.3.5.3.4 India Cancer Registry Software Market by End User
7.3.5.4 South Korea Cancer Registry Software Market
7.3.5.4.1 South Korea Cancer Registry Software Market by Type
7.3.5.4.2 South Korea Cancer Registry Software Market by Deployment Model
7.3.5.4.3 South Korea Cancer Registry Software Market by Component
7.3.5.4.4 South Korea Cancer Registry Software Market by End User
7.3.5.5 Singapore Cancer Registry Software Market
7.3.5.5.1 Singapore Cancer Registry Software Market by Type
7.3.5.5.2 Singapore Cancer Registry Software Market by Deployment Model
7.3.5.5.3 Singapore Cancer Registry Software Market by Component
7.3.5.5.4 Singapore Cancer Registry Software Market by End User
7.3.5.6 Malaysia Cancer Registry Software Market
7.3.5.6.1 Malaysia Cancer Registry Software Market by Type
7.3.5.6.2 Malaysia Cancer Registry Software Market by Deployment Model
7.3.5.6.3 Malaysia Cancer Registry Software Market by Component
7.3.5.6.4 Malaysia Cancer Registry Software Market by End User
7.3.5.7 Rest of Asia Pacific Cancer Registry Software Market
7.3.5.7.1 Rest of Asia Pacific Cancer Registry Software Market by Type
7.3.5.7.2 Rest of Asia Pacific Cancer Registry Software Market by Deployment Model
7.3.5.7.3 Rest of Asia Pacific Cancer Registry Software Market by Component
7.3.5.7.4 Rest of Asia Pacific Cancer Registry Software Market by End User
7.4 LAMEA Cancer Registry Software Market
7.4.1 LAMEA Cancer Registry Software Market by Type
7.4.1.1 LAMEA Integrated Cancer Registry Software Market by Country
7.4.1.2 LAMEA Standalone Cancer Registry Software Market by Country
7.4.2 LAMEA Cancer Registry Software Market by Deployment Model
7.4.2.1 LAMEA On-premise Cancer Registry Software Market by Country
7.4.2.2 LAMEA Cloud-based Cancer Registry Software Market by Country
7.4.3 LAMEA Cancer Registry Software Market by Component
7.4.3.1 LAMEA Commercial Cancer Registry Software Market by Country
7.4.3.2 LAMEA Public Cancer Registry Software Market by Country
7.4.4 LAMEA Cancer Registry Software Market by End User
7.4.4.1 LAMEA Government & Third party Market by Country
7.4.4.2 LAMEA Research Centers Market by Country
7.4.4.3 LAMEA Hospital & Medical Centers Market by Country
7.4.4.4 LAMEA Private Payers Market by Country
7.4.4.5 LAMEA Pharma biotech & medical device suppliers Market by Country
7.4.5 LAMEA Cancer Registry Software Market by Country
7.4.5.1 Brazil Cancer Registry Software Market
7.4.5.1.1 Brazil Cancer Registry Software Market by Type
7.4.5.1.2 Brazil Cancer Registry Software Market by Deployment Model
7.4.5.1.3 Brazil Cancer Registry Software Market by Component
7.4.5.1.4 Brazil Cancer Registry Software Market by End User
7.4.5.2 Argentina Cancer Registry Software Market
7.4.5.2.1 Argentina Cancer Registry Software Market by Type
7.4.5.2.2 Argentina Cancer Registry Software Market by Deployment Model
7.4.5.2.3 Argentina Cancer Registry Software Market by Component
7.4.5.2.4 Argentina Cancer Registry Software Market by End User
7.4.5.3 UAE Cancer Registry Software Market
7.4.5.3.1 UAE Cancer Registry Software Market by Type
7.4.5.3.2 UAE Cancer Registry Software Market by Deployment Model
7.4.5.3.3 UAE Cancer Registry Software Market by Component
7.4.5.3.4 UAE Cancer Registry Software Market by End User
7.4.5.4 Saudi Arabia Cancer Registry Software Market
7.4.5.4.1 Saudi Arabia Cancer Registry Software Market by Type
7.4.5.4.2 Saudi Arabia Cancer Registry Software Market by Deployment Model
7.4.5.4.3 Saudi Arabia Cancer Registry Software Market by Component
7.4.5.4.4 Saudi Arabia Cancer Registry Software Market by End User
7.4.5.5 South Africa Cancer Registry Software Market
7.4.5.5.1 South Africa Cancer Registry Software Market by Type
7.4.5.5.2 South Africa Cancer Registry Software Market by Deployment Model
7.4.5.5.3 South Africa Cancer Registry Software Market by Component
7.4.5.5.4 South Africa Cancer Registry Software Market by End User
7.4.5.6 Nigeria Cancer Registry Software Market
7.4.5.6.1 Nigeria Cancer Registry Software Market by Type
7.4.5.6.2 Nigeria Cancer Registry Software Market by Deployment Model
7.4.5.6.3 Nigeria Cancer Registry Software Market by Component
7.4.5.6.4 Nigeria Cancer Registry Software Market by End User
7.4.5.7 Rest of LAMEA Cancer Registry Software Market
7.4.5.7.1 Rest of LAMEA Cancer Registry Software Market by Type
7.4.5.7.2 Rest of LAMEA Cancer Registry Software Market by Deployment Model
7.4.5.7.3 Rest of LAMEA Cancer Registry Software Market by Component
7.4.5.7.4 Rest of LAMEA Cancer Registry Software Market by End User

Chapter 8. Company Profiles
8.1 IBM Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional & Segmental Analysis
8.1.4 Research & Development Expenses
8.1.5 SWOT Analysis
8.2 McKesson Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.3 Conduent, Incorporated
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Research & Development Expense
8.3.4 Recent strategies and developments:
8.3.4.1 Product Launches and Product Expansions:
8.4 Elekta AB
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.5 Ordinal Data, Inc.
8.5.1 Company Overview
8.6 Onco, Inc.
8.6.1 Company Overview
8.7 C/Net Solutions
8.7.1 Company Overview
8.8 Rocky Mountain Cancer Data System
8.8.1 Company Overview
8.9 Electronic Registry System, Inc.
8.9.1 Company Overview
8.1 Himagine Solutions, Inc.
8.10.1 Company Overview
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • IBM Corporation
  • McKesson Corporation
  • Conduent, Incorporated
  • Elekta AB
  • Ordinal Data, Inc.
  • Onco, Inc.
  • C/Net Solutions
  • Rocky Mountain Cancer Data System
  • Electronic Registry System, Inc.
  • Himagine Solutions, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll